Navigation Links
deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
Date:3/4/2008

REYKJAVIK, Iceland, March 4 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it will report its full-year 2007 financial results in a press release to be issued on Wednesday, March 12, after the close of the market in New York. The company will host a live webcast of its conference call to discuss these results and recent operating highlights on Thursday, March 13, at 8 am EDT / 12 noon GMT.

The webcast can be accessed through the Investors page of deCODE's website, http://www.decode.com, or through http://www.fulldisclosure.com. Please log in to the webcast 15 minutes prior to the scheduled start of the call. The call will be archived for at least a week on each site. For those unable to listen to the webcast because of company firewall or other issues, a digitized audio replay will also be available by telephone from approximately 10am EDT on Thursday, March 13 and for one week thereafter. The dial-in replay numbers are: 1 (800) 475-6701 in the U.S., and +1 (320) 365-3844 for those calling from outside the U.S. The access code is 914354.

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development, integration of acquired businesses, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationships, ability to obtain financing, competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission. deCODE undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.

Contacts:

deCODE genetics

Kristin H. Barkardottir

+354 570 2847

ir@decode.is


'/>"/>
SOURCE deCODE genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
2. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
3. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
4. deCODE Launches deCODEme(TM)
5. deCODE genetics Announces Third Quarter 2007 Financial Results
6. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
7. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
8. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
9. CellCyte Genetics Corp. Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases
10. Smart Genetics Announces Plans to Launch a New Alzheimers Risk Assessment Service
11. Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 2017 , ... AxioMed will be presenting its viscoelastic cervical ... Montego Bay, Jamaica from January 26-28th. “We’re excited to be presenting the benefits ... the simplicity of the surgical technique,” said Jake Lubinski, President of AxioMed. ...
(Date:1/21/2017)... ... 20, 2017 , ... G&L Scientific Inc, a leading provider ... ), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and ... This is the latest step in G&L’s expansion of its global clinical consulting ...
(Date:1/21/2017)... CA (PRWEB) , ... January 21, 2017 , ... ... our ongoing endeavors to bring to market a pioneering medical device for the ... has signed an engagement contract with Emergo, a global regulatory consultancy that helps ...
(Date:1/21/2017)... BOULDER, Colo. , Jan. 20, 2017 ... ("Bioptix" or the "Company"), announced that on January 14, ... a plan under which the Company will terminate certain ... subsidiary, Bioptix Diagnostics, Inc.  The Company commenced terminations on ... completed within 30 days.  The Company may pay severance ...
Breaking Biology Technology:
(Date:1/11/2017)... 11, 2017 Intoxalock, a leading ignition interlock ... of its patent-pending calibration device. With this new technology, ... securely upload data logs and process repairs at service ... "Fighting drunk driving through the application of cutting-edge ... large, but also for the customer who can get ...
(Date:1/6/2017)...  Delta ID Inc., a leader in consumer-grade iris ... at CES® 2017. Delta ID has collaborated with Gentex ... use of iris scanning as a secure, reliable and ... a car, and as a way to elevate the ... Delta ID and Gentex will demonstrate (booth #7326 LVCC) ...
(Date:12/22/2016)... , Dec. 20, 2016  As part of its longstanding ... leading personal genetics company, recently released its latest children,s book, ... The book focuses on the topics of inheritance and variation ... Standards (NGSS) taught in elementary school classrooms in the US. ... series by illustrator Ariana Killoran , whose previous book ...
Breaking Biology News(10 mins):